Cargando...
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
BACKGROUND: Myasthenia is a condition in which neuromuscular transmission is affected by antibodies against neuromuscular junction components (autoimmune myasthenia gravis, MG; and neonatal myasthenia gravis, NMG) or by defects in genes for neuromuscular junction proteins (congenital myasthenic synd...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2014
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387729/ https://ncbi.nlm.nih.gov/pubmed/25515947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010028.pub2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|